We aim to investigate the effects of KEAP1 on NRF2 modulations and the existing molecular background of this pathway in low/intermediate grade lung NETs by evaluating the effects of KEAP1 silencing on NRF2 and its target activity in carcinoid cell lines. The gene discussed is NFE2L2; the disease is carcinoid tumor.